BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19898437)

  • 1. Genentech obtains proof of concept for hedgehog inhibition.
    Sheridan C
    Nat Biotechnol; 2009 Nov; 27(11):968-9. PubMed ID: 19898437
    [No Abstract]   [Full Text] [Related]  

  • 2. Hedgehog hopes lifted by approval... and stung by failure.
    Allison M
    Nat Biotechnol; 2012 Mar; 30(3):203. PubMed ID: 22398601
    [No Abstract]   [Full Text] [Related]  

  • 3. Vismodegib.
    Dlugosz A; Agrawal S; Kirkpatrick P
    Nat Rev Drug Discov; 2012 Jun; 11(6):437-8. PubMed ID: 22653209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing hedgehog for the treatment of basal cell carcinoma.
    Harms KL; Dlugosz AA
    JAMA Dermatol; 2013 May; 149(5):607-8. PubMed ID: 23677088
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms of Hedgehog pathway activation in cancer and implications for therapy.
    Scales SJ; de Sauvage FJ
    Trends Pharmacol Sci; 2009 Jun; 30(6):303-12. PubMed ID: 19443052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sonic Hedgehog pathway inhibitors: from clinical trials to clinical practice.
    Yan BY; Hibler BP; Menge T; Dunn L; Ho AL; Rossi AM
    Br J Dermatol; 2019 May; 180(5):1260-1261. PubMed ID: 30693471
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulatory watch: leading hedgehog inhibitor submitted for approval as skin cancer drug.
    Nat Rev Drug Discov; 2011 Oct; 10(11):802-3. PubMed ID: 21997751
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeting the Hedgehog pathway in cancer: can the spines be smoothened?
    Ailles L; Siu LL
    Clin Cancer Res; 2011 Apr; 17(8):2071-3. PubMed ID: 21367749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hedgehog inhibitor gets landmark skin cancer approval, but questions remain for wider potential.
    Guha M
    Nat Rev Drug Discov; 2012 Mar; 11(4):257-8. PubMed ID: 22460111
    [No Abstract]   [Full Text] [Related]  

  • 10. Cells to surgery quiz: October 2014.
    Falto-Aizpurua L; Griffith RD; Abyaneh MY; Nouri K
    J Invest Dermatol; 2014 Oct; 134(10):1-2. PubMed ID: 25219654
    [No Abstract]   [Full Text] [Related]  

  • 11. Vismodegib (Erivedge) for basal cell carcinoma.
    Med Lett Drugs Ther; 2012 Jul; 54(1394):53-4. PubMed ID: 22777303
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of Hedgehog signaling for the treatment of lymphoma and CLL: a phase II study from the LYSA.
    Houot R; Soussain C; Tilly H; Haioun C; Thieblemont C; Casasnovas O; Bouabdallah K; Morschhauser F; Le Gouill S; Salles GA; Hoang-Xuan K; Choquet S; Marchand T; Laurent C; Pangault C; Lamy T
    Ann Oncol; 2016 Jul; 27(7):1349-50. PubMed ID: 27002105
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of anticancer agents targeting the Hedgehog signaling.
    Zhang X; Tian Y; Yang Y; Hao J
    Cell Mol Life Sci; 2017 Aug; 74(15):2773-2782. PubMed ID: 28314894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vismodegib: the first drug approved for advanced and metastatic basal cell carcinoma.
    Dubey AK; Dubey S; Handu SS; Qazi MA
    J Postgrad Med; 2013; 59(1):48-50. PubMed ID: 23525058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hedgehog inhibitors. New promising treatment of advanced basal cell carcinoma].
    Wolodarski M; Lapins J; Hansson J
    Lakartidningen; 2013 Apr 24-May 6; 110(17-18):886-8. PubMed ID: 23717940
    [No Abstract]   [Full Text] [Related]  

  • 16. Following the hedgehog to new cancer therapies.
    Dlugosz AA; Talpaz M
    N Engl J Med; 2009 Sep; 361(12):1202-5. PubMed ID: 19726764
    [No Abstract]   [Full Text] [Related]  

  • 17. Locally advanced and metastatic basal cell carcinoma: molecular pathways, treatment options and new targeted therapies.
    Ruiz Salas V; Alegre M; Garcés JR; Puig L
    Expert Rev Anticancer Ther; 2014 Jun; 14(6):741-9. PubMed ID: 24611655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vismodegib.
    Meiss F; Zeiser R
    Recent Results Cancer Res; 2014; 201():405-17. PubMed ID: 24756807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN loss mitigates the response of medulloblastoma to Hedgehog pathway inhibition.
    Metcalfe C; Alicke B; Crow A; Lamoureux M; Dijkgraaf GJ; Peale F; Gould SE; de Sauvage FJ
    Cancer Res; 2013 Dec; 73(23):7034-42. PubMed ID: 24154871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of Systemic Hedgehog Inhibitors in Daily Practice as Neoadjuvant Therapy.
    Tang N; Ratner D
    J Natl Compr Canc Netw; 2017 Apr; 15(4):537-543. PubMed ID: 28404762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.